Extensive skin loss and chronic wounds are still a significant challenge to clinicians: even if injured epidermis is normally able to self-renew, deep injuries can cause negative regulation of the wound healing cascade, leading to chronic wound formation. Skin-autografting surgical procedures are often limited by the poor availability of healthy tissue, whereas the use of non-self-tissues for allografts presents some severe risks. Tissue-engineered skin substitutes have recently become viable as a suitable alternative to auto- and allografts. However, biologists, biochemists, and technical engineers are still struggling to produce complex skin substitutes that can readily be transplanted in large quantities. The ambitious goal is now to construct a dermoepidermal substitute that rapidly vascularizes and optimally supports a stratifying epidermal graft on a biodegradable matrix. This review analyzes these aspects in light of the available literature and the authors’ experience.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Alonso L, Fuchs E. Stem cells of the skin epithelium. Proc Natl Acad Sci USA. 2003;100:11830–5.
Ponec M. Skin constructs for replacement of skin tissues for in vitro testing. Adv Drug Deliv Rev. 2002;54:S19–30.
De Mel A, Seifalian AM, Birchall MA. Orchestrating cell/material interactions for tissue engineering of surgical implants. Macromol Biosci. 2012;12:1010–21.
Metcalfe AD, Ferguson MW. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface. 2007;4:413–7.
Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev. 2008;60:184–98.
Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol. 2004;36:1031–7.
Mascré G, Dekoninck S, Drogat B, Youssef KK, Broheé S, Sotiropoulou PA, Simons BD, Blanpain C. Distinct contribution of stem and progenitor cells to epidermal maintenance. Nature. 2012;489:257–62.
De Rosa L, De Luca M. Cell biology: dormant and restless skin stem cells. Nature. 2012;489:215–7.
Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004;118:635–48.
Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9:283–9.
Shevchenko RV, James SL, James SE. A review of tissue-engineered skin bioconstructs available for skin reconstruction. J R Soc Interface. 2010;7:229–58.
Halim AS, Khoo TL, Mohd Yussof SJ. Biologic and synthetic skin substitutes: An overview. Indian J Plast Surg. 2010;43:S23–8.
Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. J Control Release. 2008;130:202–15.
Wolfe RA, Roi LD, Flora JD, Feller I, Cornell RG. Mortality differences and speed of wound closure among specialized burn care facilities. JAMA. 1983;250:763–6.
McHeik JN, Barrault C, Pedretti N, Garnier J, Juchaux F, Levard G, Morel F, Lecron JC, Bernard FX. Foreskin-isolated keratinocytes provide successful extemporaneous autologous paediatric skin grafts. J Tissue Eng Regen Med. 2013. doi:10.1002/term.1690
Cardinal M, Eisenbud DE, Armostrong DG, Zelen C, Driver V, Attinger C, et al. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen. 2009;17:306–11.
Kroner E, Kaiser JS, Fischer SC, Arzt E. Bioinspired polymeric surface patterns for medical applications. J Appl Biomater Funct Mater. 2012;10:287–92.
Bernerd F, Asselineau D. An organotypic model of skin to study photodamage and photoprotection in vitro. J Am Acad Dermatol. 2008;58:S155–9.
Lelièvre D, Justine P, Christiaens F, Bonaventure N, Coutet J, Marrot L, et al. The episkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency. Toxicol In Vitro. 2007;21:977–95.
Freshney RI. Culture of animal cells. A manual of basic techniques. New York: Wiley & Liss Ed; 2000.
Boehnke K, Mirancea N, Pavesio A, Fusenig NE, Boukamp P, Stark HJ. Effects of fibroblasts and microenvironment on epidermal regeneration and tissue function in long-term skin equivalents. Eur J Cell Biol. 2007;86:731–46.
Sun T, Jackson S, Haycock JW, MacNeil S. Culture of skin cells in 3D rather than 2D improves their ability to survive exposure to cytotoxic agents. J Biotechnol. 2006;122:372–81.
Fransson J, Heffler LC, Tengvall Linder M, Scheynius A. Culture of human epidermal Langerhans cells in a skin equivalent. Br J Dermatol. 1998;139:598–604.
An initial evaluation of the safety and activity of Celaderm (TM) treatment regimens in healing venous leg ulcers. Clinical trial from Shire Regenerative Medicine, Inc. U.S. National Institutes of Health (January 19, 2012) NCT00399308.
Gordley K, Cole P, Hicks J, Hollier L. A comparative, long term assessment of soft tissue substitutes: AlloDerm, Enduragen, and Dermamatrix. J Plast Reconstr Aesthet Surg. 2009;62:849–50.
Mansbridge J. Commercial considerations in tissue engineering. J Anat. 2006;209:527–32.
Lev-Tov H, Li CS, Dahle S, Isseroff RR. Cellular versus acellular matrix devices in treatment of diabetic foot ulcers: study protocol for a comparative efficacy randomized controlled trial. Trials. 2013;9:8.
Ackermann K, Lombardi Borgia S, Korting H, Mewes K, Schäfer-Korting M. The Phenion® full-thickness skin model for percutaneous absorption testing. Skin Pharmacol Physiol. 2010;23:105–12.
Stark HJ, Boehnke K, Mirancea N, Willhauck MJ, Pavesio A, Fusenig NE, et al. Epidermal homeostasis in long-term scaffold-enforced skin equivalents. J Investig Dermatol Symp Proc. 2006;11:93–105.
Lindberg K, Badylak SF. Porcine small intestinal submucosa (SIS): a bioscaffold supporting in vitro primary human epidermal cell differentiation and synthesis of basement membrane proteins. Burns. 2001;27:254–66.
Ng KW, Hutmacher DW. Reduced contraction of skin equivalent engineered using cell sheets cultured in 3D matrices. Biomaterials. 2006;27:4591–8.
Salernitano E, Migliaresi C. Composite materials for biomedical applications: a review. J Appl Biomater Biomech. 2003;1:3–18.
Liu Y, Luo H, Wang X, Takemura A, Fang YR, Jin Y, et al. In vitro construction of scaffold-free bilayered tissue-engineered skin containing capillary networks. Biomed Res Int. 2013;2013:561410. doi:10.1155/2013/561410.
Nör JE, Christensen J, Mooney DJ, Polverini PJ. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol. 1999;154:375–84.
Trochon V, Li H, Vasse M, Frankenne F, Thomaidis A, Soria J, et al. Endothelial metalloprotease-disintegrin protein (ADAM) is implicated in angiogenesis in vitro. Angiogenesis. 1998;2:277–85.
Ponec M, El Ghalbzouri A, Dijkman R, Kempenaar J, van der Pluijm G, et al. Endothelial network formed with human dermal microvascular endothelial cells in autologous multicellular skin substitutes. Angiogenesis. 2004;7:295–305.
Welss T, Basketter DA, Schroder KR. In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol In Vitro. 2004;18:231–43.
Oliver GJ, Pemberton MA, Rhodes C. An in vitro model for identifying skin corrosive chemicals. I. Initial validation. Toxicol In Vitro. 1988;2:7–17.
Stobbe JL, Drake KD, Maier KJ. Comparison of in vivo (Draize method) and in vitro (Corrositex assay) dermal corrosion values for selected industrial chemicals. Int J Toxicol. 2003;22:99–107.
ESAC Peer Review Panel Consensus Report on the EST1000 in vitro test method for 50 assessing skin corrosion in vitro. 2009.
Perkins MA, Osborne R, Rana FR, Ghassemi A, Robinson MK. Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential. Toxicol Sci. 1999;48:218–29.
Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol. 2008;84:539–49.
Maresca V, Flori E, Briganti S, Camera E, Cario-André M, Taïeb A, et al. UVA-induced modification of catalase charge properties in the epidermis is correlated with the skin phototype. J Investig Dermatol. 2006;126:182–90.
Rimondini L, Fini M, Giardino R. The microbial infection of biomaterials: A challenge for clinicians and researchers. A short review. J Appl Biomater Biomech. 2005;3:1–10.
Azzimonti B, Dell’oste V, Borgogna C, Mondini M, Gugliesi F, De Andrea M, et al. The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. Virology. 2009;388:260–9.
Borgogna C, Zavattaro E, De Andrea M, Griffin HM, Dell’Oste V, Azzimonti B, et al. Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models. Virology. 2012;423:195–204.
Tfayli A, Piot O, Draux F, Pitre F, Manfait M. Molecular characterization of reconstructed skin model by Raman microspectroscopy: comparison with excised human skin. Biopolymers. 2007;87:261–74.
Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003;26:1701–5.
Dewey CF Jr, Bussolari SR, Gimbrone MA Jr, Davies PF. The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng. 1981;103:177–85.
Conflict of interest
The authors declare that they have no conflict of interest.
About this article
Cite this article
Catalano, E., Cochis, A., Varoni, E. et al. Tissue-engineered skin substitutes: an overview. J Artif Organs 16, 397–403 (2013). https://doi.org/10.1007/s10047-013-0734-0
- Engineered skin substitute
- Skin regeneration
- Bioengineered skin
- Engineered models